Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to ... apnea FDA says shortage of GLP-1 drug tirzepatide is over Merck ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated between the government and manufacturers.

Patients lost 20.7% of body weight, disappointing investors US plan to target Wegovy in price negotiations hits shares Novo Nordisk A/S ’s blockbuster drug Wegovy was targeted for price cuts by the US ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than ...

Pfizer’s top-selling breast cancer drug Ibrance also on list Drugmakers plan to ask Trump administration to pause talks The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters ...

WASHINGTON — Popular weight loss drugs like Ozempic and Wegovy have been added to ... to generate about $6 billion for taxpayers and $1.5 billion for Medicare enrollees. Negotiated prices ...

Novo Nordisk (NVO) announced Friday that a higher-dose version of its popular obesity therapy, semaglutide, marketed as Wegovy led to 20.7% weight loss over 72 weeks compared to 17.5% weight loss ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Besides semaglutide, which Novo Nordisk sells as Ozempic, Rybelsus and Wegovy, the agency also chose other diabetes drugs, respiratory therapies and several cancer treatments. CMS’ treatment of ...